Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder [Phase 1]

View source ↗

Summary

Phase 1 trial update on balovaptan in children with autism spectrum disorder; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Balovaptan (balovaptan)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Autism Spectrum Disorder | Phase 1 | Status: TERMINATED | Results posted: 2020-10-14